Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Share News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Instem acquisition by Ichor sanctioned by UK court

Thu, 16th Nov 2023 19:30

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Andrada Mining Ltd - African technology metals mining company with a portfolio of mining and exploration assets in Namibia - Says it has received USD25 million in funding from Orion Mine Finance. Says the funding consists of GBP12.5 million unsecured tin royalty, USD2.5 million equity subscription for 30.5 million shares, and USD10 million convertible loan note. Says the tin royalty is allocated to increasing tin production at its Uis mine in Namibia. Says the remaining USD12.5 million will accelerate the lithium and tantalum revenue streams, including the expansion of Uis and exploration drilling across all of its licences. Chief Executive Anthony Viljoen says: "We are pleased to announce drawdown of the Orion funding, following the fulfilment of all conditions. This partnership with Orion will not only enable the expansion of tin production up to 2 000 tpa, but will also allow us to accelerate our wider lithium and tin development surrounding our Uis mine."

----------

Bushveld Minerals Ltd - South Africa-focused vanadium producer and energy storage solutions provider - Says finance director Tanya Chikanza resigns, giving six months' notice. Says it is investigating Chikanza regarding alleged misconduct which relates to a failure to disclose a material conflict of interest. Says it has suspended her from contractual appointment with immediate effect. Says Janandre Lamprecht will become acting finance director.

----------

Agronomics Ltd - investor in the cellular agriculture field - Says portfolio company Solar Foods Oy raises EUR8 million in series B financing round via Finnish investment organiser Springvest Oyj. Notes that existing investors have also participated in a private placement which will close in two weeks. Says existing investors include Happiness Capital and Lifeline Ventures. Notes that it has invested EUR6 million in Solar Foods so far.

----------

Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Says its proposed acquisition by Ichor Management Ltd Bidco, which is controlled by funds managed by Archimed SAS, has been sanctioned by the UK high court. Says scheme expected to become effective on November 21, with shares to be cancelled on London's AIM market.

----------

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Launches placing of shares at 19 pence per share to raise at least GBP3.0 million. Launches separate retail offer to raise up to GBP250,000 from existing shareholders. Says proceeds will be used to advance oral and inflamation programmes, roll-out of Axis-PS, study and commercialisation of acne treatment and as working capital. Chief executive Stuart Ashman says: "The funds we are looking to raise are to help with the current commercialisation and development strategy of AxisBiotix in skin health, with our latest venture beginning in acne, as well as providing a stronger financial base to support our strategic partnering discussions around three of our other business pillars."

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Nov 2023 15:08

EARNINGS AND TRADING UPDATES: Accsys narrows interim pretax loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Nov 2023 11:35

IN BRIEF: SkinBioTherapeutics share placing raises GBP3 million

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Raises GBP3.0 million through placing of 15.9 million shares at 19 pence each. Says placing was completed through an accelerated bookbuild and was "materially oversubscribed". Placing price represents a 9.5% discount to SkinBio's closing middle market price of 21p per share on November 15, the day before it launched the placing. Company says the placing shares will be admitted to AIM on Wednesday and will represent around 9.2% of its total issued share capital.

Read more
1 Nov 2023 11:55

OptiBiotix says market still "volatile" but partner sales improving

(Alliance News) - OptiBiotix Health PLC on Wednesday said sales from existing partners have improved in recent months, and that its move to focus on US and Asian markets is progressing well.

Read more
25 Oct 2023 14:39

TRADING UPDATES: SkinBio trading as expected; Sylvania output up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
25 Oct 2023 09:08

SkinBioTherapeutics launches new consumer study into acne

(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".

Read more
19 Oct 2023 12:10

IN BRIEF: SkinBio extends collaboration with Sederma for SkinBiotix

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Extends its collaboration contract with Sederma SAS, the cosmetics arm of Croda International PLC, for another 12 months. Says the extension is so Sederma can complete and assess further studies on SkinBiotix technology to look at "previously unseen beneficial properties", which could "significantly enhance commercial opportunities". Sederma will cover any costs of SkinBioTherapeutics concerning the supply of SkinBiotix for the studies."We are confident that this can lead to a wider commercialisation of our SkinbiotixTM technology into new products, which can make a great difference to consumers with a wide array of skincare needs," says CEO Stuart Ashman.

Read more
19 Oct 2023 10:37

AIM WINNERS & LOSERS: OnTheMarket surges on CoStar takeover

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
15 Sep 2023 10:18

SkinBio gets approval to launch psoriasis treatment in France

(Alliance News) - SkinBioTherapeutics PLC on Friday said it has received approval from regulators to sell AxisBiotix-Ps, a food supplement designed to treat symptoms of psoriasis, to consumers in France.

Read more
15 Sep 2023 10:11

SkinBioTherapeutics gets France approval for psoriasis supplement

(Sharecast News) - SkinBioTherapeutics has been given the green light by French regulators to introduce its food supplement, AxisBiotix-Ps, into the French market, it announced on Friday.

Read more
5 Sep 2023 17:35

TRADING UPDATES: Literacy Capital nets profit on Butternut Box sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Sep 2023 12:44

SkinBioTherapeutics selects probiotic blends for acne study

(Sharecast News) - Skin health specialist SkinBioTherapeutics updated the market on its decision on the probiotic blends to be used in a consumer volunteer study aimed at acne treatment on Tuesday.

Read more
21 Jun 2023 17:00

SkinBioTherapeutics launching psoriasis supplement in Italy

(Sharecast News) - Skin health specialist SkinBioTherapeutics has received regulatory approval to introduce 'AxisBiotix-Ps' - a food supplement designed to alleviate the symptoms associated with psoriasis - into the Italian market, it announced on Wednesday.

Read more
21 Jun 2023 10:48

IN BRIEF: SkinBioTherapeutics to launch AxisBiotix-Ps in Italy

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Receives regulatory approval to issue AxisBiotix-Ps in Italy. This follows the launch of AxisBiotix-Ps in Spain, after having received approval in March. Says the next target country for launch of the product is France, with talks with French regulators already underway. AxisBiotix-Ps is a food supplement used to alleviate Psoriasis symptoms.

Read more
14 Jun 2023 18:24

IN BRIEF: SkinBioTherapeutics knows no reason for share price fall

SkinBioTherapeutics PLC - life science company focused on skin health - Notes share price slide but says "not aware of any rationale for the movement".

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.